Treatment of Extra - Abdominal Desmoid Tumors with Chemotherapy

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2013 Nov 12

PMID 24212959

Authors

Corey Montgomery

Cynthia Emory

Sheila Adams

Jonathan Cohen

John David Pitcher

Benjamin Kyle Potter

H Thomas Temple

Affiliations

Soon will be listed here.

Abstract

Fibromatosis, or extra-abdominal desmoid tumor, is a benign disease which often has an aggressive clinical course that can be difficult to treat. We performed a retrospective review of 16 patients (12 females and four males) with a mean age of 34.2 years treated with methotrexate and vinblastine for newly diagnosed or recurrent extra-abdominal desmoid tumor. The mean age of our patient cohort was 34.2 years (range 11-70), and the mean tumor size was 11.5 cm (range 2.5-21.2 cm). The mean duration of therapy was 12 months with an average follow-up of 43 months (range 1-149 months). Fourteen of 16 patients demonstrated a clinical response to treatment. Eight of 14 patients demonstrated a radiologic decrease in tumor size. Only one patient progressed on therapy. Six patients developed recurrent symptoms after discontinuation of treatment. Chemotherapy-related symptoms including neutropenia, nausea, and vomiting were common and observed in most patients, however these side effects were mild and transient. Five patients developed peripheral neuropathy that prompted a change from vinblastine to vinorelbine during treatment. One potentially life-threatening complication (pneumocystis pneumonia) occurred which was diagnosed early and successfully treated. The use of methotrexate and vinblastine/vinorelbine in the management of fibromatosis appears to be an effective treatment with minimal treatment-related side effects.

References

Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G . High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer. 2004; 100(3):612-20. DOI: 10.1002/cncr.11937. View

Micke O, Seegenschmiedt M . Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care Study. Int J Radiat Oncol Biol Phys. 2005; 61(3):882-91. DOI: 10.1016/j.ijrobp.2004.07.705. View

Skapek S, Ferguson W, Granowetter L, Devidas M, Perez-Atayde A, Dehner L . Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol. 2007; 25(5):501-6. DOI: 10.1200/JCO.2006.08.2966. View

Giarola M, Wells D, MONDINI P, Pilotti S, Sala P, Azzarelli A . Mutations of adenomatous polyposis coli (APC) gene are uncommon in sporadic desmoid tumours. Br J Cancer. 1998; 78(5):582-7. PMC: 2063069. DOI: 10.1038/bjc.1998.544. View

Skapek S, Hawk B, Hoffer F, Dahl G, Granowetter L, Gebhardt M . Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 1998; 16(9):3021-7. DOI: 10.1200/JCO.1998.16.9.3021. View

Poritz L, Blackstein M, Berk T, Gallinger S, McLeod R, Cohen Z . Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors. Dis Colon Rectum. 2001; 44(9):1268-73. DOI: 10.1007/BF02234783. View

Schnitzler M, Cohen Z, Blackstein M, Berk T, Gallinger S, Madlensky L . Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum. 1997; 40(7):798-801. DOI: 10.1007/BF02055435. View

Nuyttens J, Rust P, Thomas Jr C, Turrisi 3rd A . Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer. 2000; 88(7):1517-23. View

Stengel G, Metze D, Dorflinger B, Luger T, Bohm M . Treatment of extra-abdominal aggressive fibromatosis with pegylated interferon. J Am Acad Dermatol. 2008; 59(2 Suppl 1):S7-9. DOI: 10.1016/j.jaad.2007.07.019. View

10.

Hosalkar H, Torbert J, Fox E, DeLaney T, Aboulafia A, Lackman R . Musculoskeletal desmoid tumors. J Am Acad Orthop Surg. 2008; 16(4):188-98. DOI: 10.5435/00124635-200804000-00002. View

11.

Rudiger H, Ngan S, Ng M, Powell G, Choong P . Radiation therapy in the treatment of desmoid tumours reduces surgical indications. Eur J Surg Oncol. 2009; 36(1):84-8. DOI: 10.1016/j.ejso.2009.07.183. View

12.

Okuno S, Edmonson J . Combination chemotherapy for desmoid tumors. Cancer. 2003; 97(4):1134-5. DOI: 10.1002/cncr.11189. View

13.

Hosalkar H, Fox E, Delaney T, Torbert J, Ogilvie C, Lackman R . Desmoid tumors and current status of management. Orthop Clin North Am. 2005; 37(1):53-63. DOI: 10.1016/j.ocl.2005.08.004. View

14.

Patel S, Evans H, Benjamin R . Combination chemotherapy in adult desmoid tumors. Cancer. 1993; 72(11):3244-7. DOI: 10.1002/1097-0142(19931201)72:11<3244::aid-cncr2820721118>3.0.co;2-d. View

15.

Shido Y, Nishida Y, Nakashima H, Katagiri H, Sugiura H, Yamada Y . Surgical treatment for local control of extremity and trunk desmoid tumors. Arch Orthop Trauma Surg. 2008; 129(7):929-33. DOI: 10.1007/s00402-008-0750-3. View

16.

Pritchard D, Nascimento A, Petersen I . Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1996; 78(6):848-54. DOI: 10.2106/00004623-199606000-00007. View

17.

Reich S, Buhrer C, Henze G . Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors. J Clin Oncol. 1999; 17(3):1086. DOI: 10.1200/JCO.1999.17.3.1086. View

18.

Fernberg J, Brosjo O, Larsson O, Soderlund V, Strander H . Interferon-induced remission in aggressive fibromatosis of the lower extremity. Acta Oncol. 1999; 38(7):971-2. DOI: 10.1080/028418699432680. View

19.

Raney B, Evans A, Granowetter L, SCHNAUFER L, Uri A, Littman P . Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics. 1987; 79(3):394-8. View

20.

Constantinidou A, Jones R, Scurr M, Al-Muderis O, Judson I . Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. Eur J Cancer. 2009; 45(17):2930-4. DOI: 10.1016/j.ejca.2009.08.016. View